Opana (Oxymorphone Hydrochloride) - Summary

OPANA SUMMARY

OPANA (oxymorphone hydrochloride) is a semi-synthetic opioid analgesic supplied in 5 mg and 10 mg tablet strengths for oral administration. The tablet strengths describe the amount of oxymorphone hydrochloride per tablet.

OPANA is indicated for the relief of moderate to severe acute pain where the use of an opioid is appropriate.

See all Opana indications & dosage >>

OPANA NEWS HIGHLIGHTS

Media Articles Related to Opana (Oxymorphone)

Health Tip: Exercising With Back Pain (HealthDay)
Source: Y! Health Back Pain News [2008.11.17]

Listen To Your Leg Pain: It Could Be Telling You Something Serious
Source: Cardiovascular / Cardiology News From Medical News Today [2008.11.15]

FDA Approves Low-dose Regimen Of Premarin Vaginal Cream To Treat Moderate To Severe Postmenopausal Dyspareunia Painful Sexual Intercourse
Source: Clinical Trials / Drug Trials News From Medical News Today [2008.11.15]

Differences In Clinical Presentation Of Interstitial Cystitis/Painful Bladder Syndrome In Patients With Or Without Sexual Abuse History
Source: Urology / Nephrology News From Medical News Today [2008.11.15]

Sites Of Pain From Interstitial Cystitis/Painful Bladder Syndrome
Source: Urology / Nephrology News From Medical News Today [2008.11.15]

more >>

Published Studies Related to Opana (Oxymorphone)

Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial. [2007.06]

Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study. [2007.02]

A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. [2007.01]

A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. [2006.03]

Effects of oxymorphone and hydromorphone on the minimum alveolar concentration of isoflurane in dogs. [2006.01]

more >>

Clinical Trials Related to Opana (Oxymorphone)

A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation) [Recruiting]

Lumbar Stenosis Outcomes Research II [Recruiting]

Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects [Recruiting]

more >>